Cardiovascular Systems Inc., a St. Paul, Minn.-based maker of a minimally-invasive catheter system for the treatment of peripheral arterial disease, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol CSII, with Morgan Stanley and Citi serving as co-lead underwriters.
The company has raised around $54 million in VC funding since 2006, from firms like Maverick Capital (15% pre-IPO stake), Easton Hunt Capital Partners (9.1%) and Mitsui & Co. (5.6%). www.cardiovascularsystemsinc.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.